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Intelectin is an extracellular animal lectin found in chor-
data. Although human and mouse intelectin-1 recognize
galactofuranosyl residues included in cell walls of vari-
ous microorganisms, the physiological function of mam-
malian intelectin had been unclear. In this study, we found
that human intelectin-1 was a serum protein and bound
to Mycobacterium bovis bacillus Calmette-Gue´rin (BCG).
Human intelectin-1-binding to BCG was inhibited by Ca2+-
depletion, galactofuranosyl disaccharide, ribose, or xylose,
and was dependent on the trimeric structure of human
intelectin-1. Although monomeric, mouse intelectin-1 bound
to BCG, with its C-terminal region contributing to ef-
ficient binding. Human intelectin-1-transfected cells not
only secreted intelectin-1 into culture supernatant but also
expressed intelectin-1 on the cell surface. The cell sur-
face intelectin-1 was not a glycosylphosphatidylinositol-
anchored membrane protein. Intelectin-1-transfected cells
captured BCG more than untransfected cells, and the BCG
adherence was inhibited by an inhibitory saccharide of
intelectin-1. Intelectin-1-preincubated cells took up BCG
more than untreated cells, but the adhesion of intelectin-1-
bound BCG was the same as that of untreated BCG. Mouse
macrophages phagocytosed BCG more efficiently in medium
containing mouse intelectin-1 than in control medium. These
results indicate that intelectin is a host defense lectin that as-




Animal lectins in extracellular fluids function as host defense
lectins, which can induce agglutination, opsonization, or com-
plement activation. Mannan-binding lectin, a typical collectin,
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is associated with mannan-binding-lectin-associated serine pro-
teases (MASPs) in serum and is an initiator of the lectin pathway
of the complement system (Endo et al. 2006). Pulmonary surfac-
tant protein A, a collectin, functions as an opsonin using the C1q
receptor or the surfactant protein A receptor SP-R210 (Kuroki
et al. 2007). L-Ficolin in serum is also an opsonin (Matsushita
et al. 1996) and a complement activator associated with MASPs
(Endo et al. 2006). These observations suggest that many animal
lectins in extracellular fluid can enhance phagocytosis and con-
tribute to innate immunity against pathogenic microorganisms.
Intelectin is a soluble protein secreted into extracellular fluid
(Tsuji et al. 2001). Mammalian intelectin is present in the intesti-
nal lumen (Wrackmeyer et al. 2006), and intelectin homologs
in ascidian (Abe et al. 1999), lamprey (GenBank database ac-
cession number AB055981), fish (Russell et al. 2008), and frog
(AB061238, AB061239) (Roberson et al. 1985) are found in
serum. Human intelectin-1 is a disulfide-linked homotrimer
and a Ca2+-dependent lectin with affinity for galactofuranosyl
residues and ribose, but it is not a C-type lectin or a ficolin
(Tsuji et al. 2007). Human intelectin-1 binds to arabinogalactan
of Nocardia rubra containing galactofuranosyl residues (Tsuji
et al. 2001). Galactofuranosyl residues, which are not found
on mammalian tissues, are contained in the cell walls of var-
ious microorganisms, including Nocardia rubra (Daffe et al.
1993), Mycobacterium tuberculosis (Pedersen and Turco 2003),
Streptococcus oralis (Abeygunawardana et al. 1991), As-
pergillus fumigatus (Leitao et al. 2003), Leishmania major, and
Trypanosoma cruzi (Suzuki et al. 1997). Furthermore, mRNA
expression of intelectin increases during immune responses,
such as in infections (Pemberton et al. 2004; Datta et al. 2005;
Chang and Nie 2007; French et al. 2008; Takano et al. 2008)
and asthma (Kuperman et al. 2005). On the basis of these obser-
vations, it is proposed that intelectin plays a role in host defense
against invading pathogenic microorganisms.
In the present study, we found that human intelectin-1 is
a serum protein that binds to Mycobacterium bovis bacillus
Calmette-Gue´rin (BCG). Secreted intelectin-1 appears to de-
posit on mammalian cell surfaces through an autocrine and/or
paracrine mechanism. The deposition of intelectin-1 on epithe-
lial cell lines assists in the capture of BCG. Mouse macrophages
phagocytosed BCG more efficiently in the medium containing
mouse intelectin-1 than in the control medium. These results
suggest that intelectin is a host defense lectin that assists in
phagocytic clearance of microorganisms.
Results
Binding of intelectin-1 to BCG
Human intelectin-1 was purified from serum by using
galactose–Sepharose. Serum intelectin-1 showed a similar band
c© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org 518
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Fig. 1. Binding of human serum intelectin-1 to BCG. Recombinant human
intelectin-1 (Recombinant) or human intelectin-1 in serum (Serum) was
purified by using galactose–Sepharose (Gal-Sepharose) or ultraviolet-killed
BCG (BCG), and then eluted with 100 mM ribose, resolved by 10%
SDS–PAGE under nonreducing (A and B) or reducing conditions (A), and
detected by Western blotting, as described in Material and methods. Human
intelectin-1 was not precipitated with BCG from serum containing 10 mM
EDTA (EDTA serum).
to recombinant intelectin-1 on Western blotting under nonreduc-
ing (Figure 1A, left panel) and reducing conditions (Figure 1A,
right panel). Recombinant human intelectin-1 is a 120-kDa
disulfide-linked homotrimer (Tsuji et al. 2007). Thus, this result
indicates that intelectin-1 is present in human serum as a trimer.
The concentration of intelectin-1 in human plasma was mea-
sured by an enzyme-linked immunosorbent assay (ELISA) and
was found to be 95.5 ± 41.4 ng/mL (mean ± SD) in a cohort of
normal, healthy adult donors (n = 17, 40.8 ± 7.2 years old).
To determine whether serum intelectin-1 binds to bacteria
whose cell walls contain galactofuranosyl residues, ultraviolet-
killed BCG with intact membranes was used for the binding
studies. Intelectin-1 was precipitated from serum in the presence
of Ca2+ by using ultraviolet-killed BCG (Figure 1B).
The binding of intelectin-1 to BCG was further con-
firmed cytometrically by using anti-intelectin-1 antibodies.
For biological safety, heat-killed BCG (HK-BCG) was used
in the following studies. Recombinant human intelectin-1
bound to HK-BCG in the presence of Ca2+ (Figure 2A).
This binding was completely inhibited by a disaccharide
containing galactofuranosyl residue, 2-acetamido-2-deoxy-4-
O-beta-D-galactofuranosyl-D-glucopyranose (GalfG) but not
a galactopyranoside isomer, 2-acetamido-2-deoxy-4-O-beta-D-
galactopyranosyl-D-glucopyranose (Figure 2B). In addition, the
binding of intelectin-1 to HK-BCG was completely inhibited
by ribose and xylose; partially inhibited by galactose, arabi-
nose, or lyxose; and not inhibited by glucose or mannose (Fig-
ure 2B).These results are similar to previous observations of the
competitive inhibition of intelectin-1 binding to arabinogalac-
Fig. 2. Flow cytometric analysis of intelectin-1-binding to BCG. HK-BCG
was incubated in culture supernatant of human intelectin-1-transfected RK-13
cells with (thin line in A) or without (bold line in A) 10 mM EDTA, or with
100 mM saccharide (B). The bacteria were washed, incubated with antibodies,
and analyzed by flow cytometry. Human intelectin-1 (hITLN1) binding with
each saccharide was determined from mean fluorescence intensity and is
expressed as the percentage of intelectin-1 binding to BCG without saccharide.
GalfG, 2-acetamido-2-deoxy-4-O-beta-D-galactofuranosyl-D-glucopyranose;
GalpG, 2-acetamido-2-deoxy-4-O-beta-D-galactopyranosyl-D-glucopyranose;
Glc, glucose; Gal, galactose; Man, mannose; Ara, arabinose; Lyx, lyxose; Rib,
ribose; Xyl, xylose.
tan of Nocardia rubra by saccharides (Tsuji et al. 2001). Thus,
intelectin-1 likely binds to arabinogalactan on BCG as well.
Structure of human intelectin-1 required for binding to BCG
To investigate whether the trimeric structure of human
intelectin-1 is required to bind BCG, we precipitated point-
mutated intelectin-1 with HK-BCG from culture super-
natants containing monomeric, dimeric, or trimeric intelectin-1.
Monomeric intelectin-1 bound to galactose–Sepharose but
not to HK-BCG (Figure 3, lanes 1 and 4). Dimeric
intelectin-1 and trimeric native intelectin-1 bound to both
galactose–Sepharose and HK-BCG; however, more intelectin-1
bound to galactose–Sepharose than to HK-BCG (Figure 3, lanes
2, 3, 5, and 6). These results suggest that an oligomerized struc-
ture is required for human intelectin-1 for binding to HK-BCG,
unlike binding to galactose–Sepharose.
To investigate whether another mammalian intelectin binds
to BCG, mouse intelectin-1 was tested. Although mouse
intelectin-1 is monomeric (Tsuji et al. 2007), mouse intelectin-1
bound to both HK-BCG and galactose–Sepharose in a similar
proportion (Figure 4, lanes 4 and 8). Thus, mouse intelectin-1
does not require an oligomerized structure for the binding to
HK-BCG.
To determine the regions of human and mouse intelectin-1
that are associated with binding to HK-BCG, chimeras formed
between human and mouse intelectin-1 were used. A chimeric
molecule consisting of the N-terminus of human intelectin-1
and the C-terminus of mouse intelectin-1 (Hu/Mo) was a trimer,
and this molecule bound to HK-BCG in a proportion similar to
that of mouse intelectin-1 (Figure 4, lanes 2 and 6). A chimeric
molecule consisting of the N-terminus of mouse intelectin-1 and
the C-terminus of human intelectin-1 (Mo/Hu) was a monomer
and did not bind to HK-BCG (Figure 4, lanes 3 and 7). These
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Fig. 3. The requirement of the oligomeric structure of human intelectin-1 for
binding to BCG. As described in Material and methods, monomeric, dimeric,
or trimeric recombinant human intelectin-1 was precipitated with
galactose–Sepharose (Gal-Sepharose) or HK-BCG (BCG), eluted with 10 mM
EDTA, resolved by nonreducing SDS–PAGE, and stained with Coomassie
blue. Recombinant human intelectin-1 with Ser substituted for both Cys-31
and Cys-48 was monomeric, recombinant human intelectin-1 with Ser
substituted for Cys-48 was mainly dimeric, and intact human intelectin-1
(hITLN1) was trimeric.
Fig. 4. The binding of mouse intelectin-1 to BCG. Recombinant human
intelectin-1 was precipitated with galactose–Sepharose (Gal-Sepharose) or
HK-BCG (BCG), eluted with 10 mM EDTA, resolved by nonreducing
SDS–PAGE, and stained with Coomassie blue. hITLN-1, human intelectin-1;
Hu/Mo, a chimeric molecule consisting of N-terminus of human intelectin-1
and C-terminus of mouse intelectin-1; Mo/Hu, a chimeric molecule consisting
of N-terminus of mouse intelectin-1 and C-terminus of human intelectin-1;
mITLN1, mouse intelectin-1.
results suggest that the C-terminal region of mouse intelectin-1
contributes to efficient binding to BCG.
Accumulation of intelectin-1 on cell surfaces
Although intelectin is a serum protein (Figure 1), swine int-
electin is found on the cellular membrane of epithelial cells
(Wrackmeyer et al. 2006). Thus, secreted intelectin-1 may accu-
mulate on the cell surface through an autocrine and/or paracrine
mechanism. By flow cytometric analysis, intelectin-1 was de-
tected on the cell surfaces of RK-13 rabbit kidney epithelial
cells and L929 mouse fibroblastic cells that were stably trans-
fected with human intelectin-1 (Figure 5A and B). Intelectin-1
has a similar, although incomplete, C-terminal region to the
signal sequence for the glycosylphosphatidylinositol (GPI) an-
chor. To investigate whether cell surface intelectin-1 is a GPI-
anchored membrane protein, we attempted to release cell sur-
face intelectin-1 by phosphatidylinositol-specific phospholipase
C (PI-PLC) digestion. Prion protein, a GPI-anchored protein,
expressed on RK-13 cells was removed from the cell surface
by PI-PLC treatment (Figure 5C). However, intelectin-1 was
not released by PI-PLC (Figure 5D). These results indicate that
the cell surface intelectin-1 is not a GPI-anchored membrane
protein.
We further investigated whether secreted intelectin-1 was
a GPI-anchored protein that was released or proteolytically
cleaved from the cell membrane. Since a GPI-anchored pro-
tein has its C-terminal signal peptide cleaved and replaced
by a GPI anchor, a mature GPI-anchored protein does not
have the C-terminal amino acid sequences in the extracel-
lular space. Tryptic peptides of purified secreted intelectin-1
were analyzed by matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF), and 13 peptides were identi-
fied (Figure 6). The calculated molecular weight of peptide
13, the C-terminal peptide of human intelectin-1 (residues
302–313), is 1424.64, which is almost identical to the molec-
ular mass of the ion identified at 1424.51 (Figure 6, arrow).
This result indicates that secreted intelectin-1 includes the C-
terminal peptide of intelectin-1. Secreted intelectin-1 is the full-
length protein; it is neither a GPI-anchored protein nor a prote-
olytic fragment.
Taken together, these results indicate that secreted intelectin-1
in culture supernatant deposits on the cell surface through an
autocrine and/or paracrine mechanism.
Capture of BCG by intelectin-1 on the cell membrane
To determine whether intelectin-1 on the cellular mem-
branes enhances the capture of bacteria, RK-13 cells trans-
fected with human intelectin-1 were incubated with fluores-
cein isothiocyanate-labeled HK-BCG (FITC-BCG). As shown
in Figure 7A, human intelectin-1-transfected RK-13 cells cap-
tured more FITC-BCG than untransfected RK-13 cells. Human
intelectin-1-transfected RK-13 cells bound twice the amount
of FITC-BCG as compared to untransfected RK-13 cells
(Figure 7B, BCG alone). As shown in Figure 7B, the increased
FITC-BCG binding to human intelectin-1-transfected RK-13
cells was reduced by ribose, which competitively inhibited the
binding of human intelectin-1 to HK-BCG (Figure 2B). FITC-
BCG binding to untransfected RK-13 cells was not affected
by saccharides. These results indicate that human intelectin-1
on the cell surface enhances the capture of BCG. GalfG, the in-
hibitory saccharide containing a galactofuranosyl residue, could
not be used in these experiments because it decreased the sur-
vival rate of cells at the inhibitory concentration of binding (data
not shown).
In these experiments, most captured FITC-BCG was not
internalized, since the fluorescence of the captured FITC-
BCG was quenched with trypan blue (data not shown). Thus,
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Fig. 5. Flow cytometric analysis of intelectin-1 on the cell surface. The cells were treated with PI-PLC, incubated with antibodies, and analyzed by flow cytometry.
(A and B) Untransfected RK-13 cells (gray thin line in A), untransfected L929 cells (gray thin line in B), human intelectin-1-transfected RK-13 cells
(hITLN1-RK13) (black bold line in A), or human intelectin-1-transfected L929 cells (hITLN1-L929) (black bold line in B) were treated with anti-intelectin
antibodies. The fluorescence level of cells treated with unimmunized rabbit IgG was similar to that of untransfected cells treated with anti-intelectin antibodies
(data not shown). (C and D) Untransfected RK-13 cells (black thin line in C and D), untreated prion protein-transfected RK-13 cells (PrP-RK13) (black bold line in
C), PI-PLC-treated PrP-RK13 cells (gray bold line in C), untreated hITLN1-RK13 cells (black bold line in D), or PI-PLC-treated hITLN1-RK13 cells (gray bold
line in D) were treated with anti-prion protein (C) or anti-intelectin (D) antibodies.
Fig. 6. MALDI-TOF spectrum of tryptic peptides of human intelectin-1. The amino acid sequences identified on the mass spectrum are indicated by underlining in
human intelectin-1 sequence at the top of the figure. The gray characters indicate the signal peptide.
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Fig. 7. Binding of BCG to cells through intelectin-1. (A) Untransfected RK-13
cells (RK13), human intelectin-1-transfected RK-13 cells (hITLN1-RK13), or
mouse intelectin-1-transfected RK-13 cells (mITLN1-RK13) were cultured
with FITC-BCG. These cells were washed, fixed with paraformaldehyde, and
stained with propidium iodide (PI). The figures are representative photographs.
(B) RK13 cells or hITLN1-RK13 cells were cultured with FITC-BCG in the
medium containing 100 mM glucose (BCG + Glc), 100 mM ribose (BCG +
Rib), or no added carbohydrate (BCG alone). Mean fluorescence intensity of
FITC-BCG-bound cells was measured by flow cytometry. Values represent the
means ± SD of triplicate determinations. Differences between mean values for
the FITC-BCG binding were analyzed by Student’s t-test. ∗, P < 0.001
compared with the corresponding treatment in the RK13. #, P < 0.001
compared with the treatment with BCG alone in hITLN1-RK13.
intelectin-1 enhances the adhesion of BCG to cell surfaces but
not the ingestion of BCG into nonphagocytic cells such as RK-
13 cells.
We investigated whether the exogenous intelectin-1 deposited
on the cell surface functioned as an acceptor for BCG on cells
and/or whether soluble intelectin-1 had an opsonic effect. As
shown in Figure 8B, RK-13 cells preincubated with intelectin-1
took up more FITC-BCG than untreated RK-13 cells. Their
binding level was comparable to that of intelectin-1-transfected
RK-13 cells (Figure 8A). Surprisingly, pretreatment of FITC-
BCG with intelectin-1 caused little increase in binding of BCG
to untreated RK-13 cells (Figure 8C). These results suggest that
secreted intelectin-1 is deposited on the cellular membranes in
an autocrine and/or paracrine manner and functions as a receptor
for pathogens rather than as an opsonin.
For comparative studies, we examined whether mouse
intelectin-1-transfected RK-13 cells or mouse intelectin-1-
pretreated RK-13 cells enhanced binding to FITC-BCG. As
shown in Figures 7A and Figure 8, RK-13 cells either trans-
fected or pretreated with mouse intelectin-1 demonstrate in-
creased BCG binding to cell surfaces compared to untreated
RK-13 cells. The effects of mouse intelectin-1 on binding were
Fig. 8. Capture of BCG by exogenous intelectin-1. Mean fluorescence
intensity of FITC-BCG-bound cells was measured by flow cytometry. Values
represent the means ± SD of triplicate determinations. Differences between
mean values for the FITC-BCG binding were analyzed by Student’s t-test.
(A) Untransfected RK-13 cells (open column), human intelectin-1
(hITLN1)-transfected RK13 cells (gray closed column), or mouse intelectin-1
(mITLN1)-transfected RK-13 cells (closed column) were cultured with
untreated FITC-BCG. ∗, P < 0.005 compared with the untransfected RK13
cells. (B) Untreated RK-13 cells (open column), RK-13 cells preincubated
with culture supernatant containing hITLN1 (gray closed column), or RK-13
cells preincubated with culture supernatant containing mITLN1 (closed
column) were cultured with untreated FITC-BCG. #, P < 0.005 compared with
the untreated RK13 cells. (C) Untreated RK-13 cells were cultured with
FITC-BCG preincubated with mock culture supernatant (open column) or
culture supernatant containing hITLN1 (gray closed column) or mITLN1
(closed column).
comparable to those of human intelectin-1 (Figure 8A and B).
Similarly to its human homolog, soluble mouse intelectin-1 did
not show any opsonic activity (Figure 8C). These results indi-
cate that mouse intelectin-1 also enhances the capture of BCG
on cell surfaces.
Phagocytosis of BCG by intelectin-1
To investigate the effects of intelectin-1 on macrophage phago-
cytosis, mouse alveolar macrophages were incubated with HK-
BCG in culture supernatant containing recombinant mouse
intelectin-1. Approximately 25% of the macrophages that were
cultured with intelectin-1 phagocytosed HK-BCG, and approx-
imately 10% of the macrophages phagocytosed HK-BCG in the
medium without intelectin-1 (Figure 9). These results suggest
that exogenous intelectin-1 enhances phagocytosis of BCG by
macrophages. However, when untreated macrophages were in-
cubated with mouse intelectin-1-bound HK-BCG, no increase in
phagocytosis was observed, indicating that mouse intelectin-1
has no opsonic effects (data not shown).
Discussion
Some homologs of intelectin have been found in chordates.
Xenopus laevis cortical granule lectin has a role in forming
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Fig. 9. Phagocytosis of BCG using mouse intelectin-1. Mouse alveolar
macrophages were incubated with HK-BCG in culture supernatants of
untransfected RK-13 cells (Mock) or mouse intelectin-1-transfected RK13
cells (mITLN1). The percentage of BCG-ingesting macrophages (Phagocytosis
Rate) was determined by counting at least 500 macrophages from each
independent culture. Values represent the means ± SD of triplicate
determinations. Differences between mean values were analyzed by Student’s
t-test.
the fertilization envelope (Gerton and Hedrick 1986; Quill and
Hedrick 1996). Ascidian galactose-specific lectin (Abe et al.
1999), lamprey serum lectin (accession number AB055981),
rainbow trout plasma intelectin (Russell et al. 2008), Xenopus
laevis serum lectin types 1 and 2 (Roberson et al. 1985), and
human intelectin-1 (Figure 1A) have been found to be present
in serum. In this study, we demonstrated that human serum
intelectin-1 binds to BCG and that BCG adheres to intelectin-
1-secreting cells. In addition, exogenous mouse intelectin-1 en-
hances the phagocytosis of BCG by macrophages. These re-
sults suggest that mammalian intelectin enhances phagocytic
clearance of invading organisms. The phagocytosis-enhancing
function of intelectin may be a basic function in chordates.
All intelectin homologs lack transmembrane domains, and
human intelectin-1 is present in serum and in the culture super-
natants of intelectin-1-transfected cells (Figure 1A). Although
these observations suggest that intelectin-1 is a secretory protein,
some reports have indicated that intelectin and its homologs are
also present on cell surfaces (Nomura et al. 1998; Suzuki et al.
2001; Wrackmeyer et al. 2006). In this study, we confirmed that
human intelectin-1 is present on the cell surface (Figure 5). It has
been proposed that intelectin-1 is GPI anchored by its C-terminal
peptide, and it has been reported that the human intelectin-
1/intestinal lactoferrin receptor is a GPI-anchored protein on
intestinal epithelial cells (Suzuki et al. 2001). However, the cell
surface intelectin-1 on intelectin-1-transfected RK-13 cells was
resistant to digestion by PI-PLC, although the prion protein,
which is known to be GPI anchored, expressed on RK-13 cells
was removed by PI-PLC (Figure 5). These results indicate that
the cell surface intelectin-1 is not a GPI-anchored protein but
is a secretory protein that binds to the cell surface. Intelectin-1
found on normotopic tissues may include an alternative form
that is GPI anchored to the cell membranes. However, mea-
surements of serum intelectin-1 (Figure 1A), the C-terminal
peptide of secreted intelectin-1 (Figure 6), and the C-terminal
peptide of intelectin-1 in intestinal mucosa (Wrackmeyer et al.
2006) indicate that the major form of intelectin-1 is a secretory
protein.
Because the amount of intelectin-1 bound to cell surfaces
is not affected by Ca2+-depletion with ethylenediamine tetra-
acetic acid (EDTA) (data not shown), intelectin-1 does not bind
via saccharide chains on cell surfaces. The receptor for int-
electin has not been identified, but intelectin has been reported
to deposit on epithelial cell rafts (Wrackmeyer et al. 2006).
Galectin-4, a soluble galactose-binding lectin, interacts with sul-
fatides in lipid rafts in intestinal epithelial cell lines (Delacour
et al. 2005). The similarity between galectin-4 and intelectin-1
in their affinity for galactose and tissue distribution reminds that
cell surface intelectin-1 may also bind to glycolipids that have
accumulated in rafts. Their deposition on lipid rafts could be ad-
vantageous in trapping pathogens in the intestinal lumen, since
lipid rafts accumulate on the apical membrane of epithelial cells.
The receptors for intelectin-1 require further characterization.
The cells that initially encounter mycobacteria in the alve-
olar space are macrophages and lung epithelial cells. Invad-
ing mycobacteria are internalized by macrophages, and then
multiply within macrophages and in type II alveolar epithe-
lial cells, which are not professional phagocytes (Bermudez and
Goodman 1996). Because human airway epithelial cells express
intelectin-1 during inflammation (Kuperman et al. 2005), it is
possible that cell surface intelectin-1 mediates mycobacterial
infection of lung epithelial cells. Similarly, intestinal epithelial
cells, which can be invaded by mycobacteria (Bermudez et al.
1997; Sangari et al. 2001), have intelectin-1 on their surfaces
(Wrackmeyer et al. 2006). The intelectin-1-mediated capture
of mycobacteria by epithelial cells may play a unique role in
host responses to mycobacterial infection. The internalization
of mycobacteria by epithelial cells results in the production of
soluble factors including tumor necrosis factor-α and granu-
locyte macrophage colony-stimulating factor, which potentiate
macrophage anti-mycobacterial activities (Sato et al. 2002). Al-
ternatively, mycobacteria internalized by epithelial cells may not
be attacked by activated macrophages (Bermudez and Goodman
1996; Bermudez et al. 1997; Sangari et al. 2001).
Mouse intelectin-1 is monomeric. Mouse intelectin-1 mi-
grated farther than trimeric or monomeric human intelectin-1
using native polyacrylamide gel electrophoresis (supplemen-
tary data). Furthermore, mouse intelectin-1 was detected
as a monomer using MALDI-TOF analysis (Tsuji et al.
2007). Monomeric mouse intelectin-1 binds to BCG, although
an oligomerized structure is required in order for human
intelectin-1 binding to BCG to occur (Figures 3 and 4). These
results suggest that mouse intelectin-1 binds to BCG more effi-
ciently than human intelectin-1. Mouse intelectin-1 might have
evolved as a defense lectin against mycobacteria. There are
marked pathological differences in the response to mycobac-
terial infections in humans and mice with respect to control
of initial infection, delayed-type hypersensitivity response, and
granuloma formation (Orme et al. 2001; Flynn 2006). The gran-
ulomatous reaction in mice does not result in typical caseous
necrosis and cavity formation, and the murine immune response
to mycobacteria may be more robust than necessary to control
the infection (Flynn 2006). It has been proposed that these dif-
ferences result from differences in the innate immune system
between humans and mice. For example, mice lack CD1b and
CD1c, which present mycobacterial lipids (Orme 2003; Sko¨ld
and Behar 2003). Our results further suggest that the molec-
ular and biochemical distinctions between mouse and human
intelectin-1 may also contribute to the differential immune re-
sponses against mycobacteria between the two species. A re-
cent report indicates no significant modification of immune
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responses or clearance of Mycobacterium tuberculosis in mouse
intelectin-1 transgenic mice (Voehringer et al. 2007). An ex-
cessive level of endogenous mouse intelectin-1 does not influ-
ence the host defense against mycobacteria. We observed that
exogenous mouse intelectin-1 enhanced phagocytosis of BCG
by macrophages (Figure 9). However, investigations of mouse
intelectin-1 are limited due to the lack of anti-mouse intelectin
antibodies with sufficient affinity for use in flow cytometric anal-
ysis or Western blotting. Moreover, mouse intelectin-1 has little
affinity for monosaccharides that do not influence cell viability
at the inhibitory concentration of binding (Tsuji et al. 2007). It
is therefore necessary to further study the roles of endogenous
intelectin-1 by employing intelectin-1-deficient conditions.
Although intelectin-1 deposited on cells enhanced the ad-
hesion of BCG to cell surfaces, intelectin-1 subjected to BCG-
prebinding did not function as an opsonin (Figure 8). Intelectin-1
affinity purified by galactose–Sepharose tends to become insol-
uble and inactive in the presence of Ca2+ (Tsuji et al. 2001).
Thus, the conformation of intelectin-1 may change after binding
to ligands, and intelectin-1 may subsequently lose the structure
required for binding to the cell surface. Although this change
decreases the opsonic effect of intelectin-1, it may activate other
phagocytosis-enhancing systems. Ficolins and mannan-binding
lectin, typical serum lectins, function as weak opsonins but are
strong enhancers of phagocytosis. They activate the host com-
plement system through associated MASPs and opsonize lig-
ands with iC3b (Endo et al. 2006). Human intelectin-1 had
no association with MASPs (data not shown). However, it is
possible that serum intelectin-1 binding to bacteria activates
complement using a serum protease.
In conclusion, we demonstrate that serum intelectin-1 binds
to mycobacteria and that intelectin-1 assists in capturing my-
cobacteria on the cell surface. This is the first report of




Anti-intelectin-1 antibodies, plasmids, cDNAs, intelectin-1-
transfected cells, or prion protein-transfected RK-13 cells
were prepared as described previously (Tsuji et al. 2007;
Sakudo et al. 2008). In some experiments, recombinant
intelectin-1 was used without purification from culture super-
natant of intelectin-1-transfected cells because purified and
concentrated intelectin-1 becomes insoluble and inactive in
the presence of Ca2+. Galactose–Sepharose was produced
by incubating epoxy-activated Sepharose 6B (GE Healthcare
UK Ltd, Buckinghamshire) with galactose according to the
manufacturer’s instructions. 2-Acetamido-2-deoxy-4-O-beta-D-
galactofuranosyl-D-glucopyranose (GalfG) was obtained from
Toronto Research Chemicals Inc. (North York, ON, Canada).
BCG Tokyo 172 strain was obtained from Nihon BCG Inc.
(Tokyo, Japan).
Purification of human intelectin-1 from serum
Human intelectin-1 was precipitated at 4◦C with
galactose–Sepharose from fresh human serum or culture su-
pernatant of human intelectin-1-transfected RK-13 cells. After
washing three times with 20 mM Tris-buffered saline (pH 7.6)
(TBS) containing 0.1% Triton-X100 and 2 mM CaCl2, human
intelectin-1 was eluted with TBS containing 100 mM ribose,
0.1% Triton-X100, and 2 mM CaCl2. Serum intelectin-1 was
also precipitated at 4◦C with 1 mg of ultraviolet-killed BCG
from fresh human serum with or without 10 mM EDTA.
After centrifuging and removing supernatants, intelectin-1 was
eluted with TBS containing 100 mM ribose and 2 mM CaCl2.
The eluted intelectin-1 was resolved by 10% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) under
nonreducing or reducing conditions and was transferred to
polyvinylidene difluoride membranes (Immobilon-P, Millipore,
Billerica, MA). The membranes were blocked with 5% nonfat
milk, and then treated for 3 h with 1 μg/mL affinity-purified
rabbit anti-intelectin antibodies in 5% nonfat milk. After
washing, the membranes were treated with horseradish
peroxidase-conjugated donkey anti-rabbit IgG (GE Healthcare
UK Ltd) and developed with the ECL Advance substrate (GE
Healthcare UK Ltd).
ELISA
The concentration of intelectin-1 in human plasma was mea-
sured by sandwich ELISA. Heparinized human plasma was
obtained from 17 healthy volunteers (7 males and 10 fe-
males) from 32 to 59 years old. The intelectin-1 in plasma
was captured by affinity-purified rabbit anti-intelectin antibod-
ies immobilized on 96-well plates and washed three times with
TBS containing 0.05% Tween 20. The plates were incubated
with TBS containing biotinylated rat anti-intelectin antibodies,
0.05% Tween 20, and 0.2% bovine serum albumin (BSA). Af-
ter washing, the plates were incubated with TBS containing
horseradish peroxidase-conjugated streptavidin (Thermo Fisher
Scientific Inc., Rockford, IL), 0.05% Tween 20, and 0.2% BSA,
washed, developed with 3,3′,5,5′-tetramethylbenzidine (Thermo
Fisher Scientific Inc.), and the absorbance at 450 nm was de-
termined. Recombinant human intelectin-1 for standards was
purified from human intelectin-1-transfected RK-13 cells by
using galactose–Sepharose (Tsuji et al. 2001). The concentra-
tion of intelectin-1 standard was estimated on the basis of the
absorbance at 280 nm and the predicted extinction coefficient
(Mach et al. 1992) of human intelectin-1. Experimental pro-
tocols were approved by the Ethical Committee of Kanagawa
Cancer Center.
Flow cytometric analysis for intelectin-1 bound to the cell
surface
HK-BCG was incubated for 30 min at 4◦C with culture super-
natant of human intelectin-1-transfected RK-13 cells. The bac-
teria were washed twice with 10 mM 2-[4-(2-hydroxyethyl)-1-
piperazinyl]ethanesulfonic acid (HEPES)-buffered saline
(pH 7.4) containing 0.1% BSA, 0.1% NaN3, and 2 mM CaCl2
(HBSC). Then, the intelectin-1-bound bacteria were incubated
with HBSC containing 1 μg/mL affinity-purified rabbit anti-
intelectin antibodies preadsorbed with HK-BCG, washed twice,
and counterstained with fluorescein isothiocyanate-conjugated
donkey anti-rabbit IgG F(ab′)2. After washing with HBSC, the
mean fluorescence intensity of binding antibodies was analyzed
on a FACSCalibur (BD Biosciences, San Jose, CA).
Human intelectin-1 or prion protein on the cells was mea-
sured on a flow cytometer. The prion protein was used as a
control of GPI-anchored protein (Stahl and Prusiner 1991).
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Capture of mycobacteria through intelectin-1
After culturing confluent intelectin-1- or prion-protein-
transfected cell or untransfected cell monolayers for 2 days in
Eagle’s minimum essential medium containing 5% fetal bovine
serum, the cells were harvested with HEPES-buffered saline
containing 10 mM EDTA, 0.1% BSA, and 0.1% NaN3. The
harvested cells (1 × 106 cells) were incubated at 37◦C for
30 min with or without 0.1 units/mL PI-PLC (Sigma) in
phosphate-buffered saline containing 0.1% BSA and 0.1%
NaN3, washed twice with HBSC, and then incubated with HBSC
containing 1 μg/mL affinity-purified rabbit anti-intelectin anti-
bodies preadsorbed with RK-13 cells or 1 μg/mL anti-prion
protein, SAF32 (SPI-bio, Montigny-le-Bretonneux, France).
After washing, the cells were counterstained with fluorescein
isothiocyanate-conjugated goat anti-rabbit IgG F(ab′)2 or fluo-
rescein isothiocyanate-conjugated goat anti-mouse IgG F(ab′)2,
respectively. The binding antibodies were analyzed on an EPICS
Altra (Beckman Coulter, Inc., Fullerton, CA).
Precipitation of recombinant intelectin-1 with
galactose–Sepharose or HK-BCG
Recombinant intelectin-1 was precipitated at 4◦C for 18 h
with galactose–Sepharose or HK-BCG from culture supernatant
of intelectin-1-transfected RK-13 cells. After washing three
times with HEPES-buffered saline containing 2 mM CaCl2,
intelectin-1 was eluted with TBS containing 10 mM EDTA.
The eluted intelectin-1 was separated on a 10% SDS–PAGE gel
under nonreducing conditions and stained with Coomassie blue.
As described previously (Tsuji et al. 2007), monomeric or
dimeric intelectin-1 was prepared as the recombinant human
intelectin-1 with Ser substituted for both Cys-31 and Cys-48
residues or Cys-48 residue, respectively. Both recombinant pro-
teins showed a 40-kDa band on SDS–PAGE under reducing con-
ditions (data not shown). Western blotting using anti-intelectin-1
antibodies showed that the 32-kDa, 60-kDa, or 120-kDa band
shown in Figure 3 was intelectin-1 peptide (Tsuji et al. 2007).
The 55-kDa band present in all lanes has not been identified.
MALDI-TOF
MALDI-TOF mass spectrometry was performed on an Applied
Biosystems Voyager DE pro biospectrometry workstation (Ap-
plied Biosystems, Foster City, CA). Proteins were reduced with
tris(2-carboxyethyl)phosphine hydrochloride (Thermo Fisher
Scientific Inc.) and alkylated with iodoacetamide, and then di-
gested for 24 h with modified trypsin (Promega, Madison, WI).
The matrix used for MALDI-TOF was alpha-cyano-4-hydroxy-
cinnamic acid (Sigma) in 0.05% trifluoroacetic acid. Mass spec-
trometry conditions were optimized for intact IgG.
Binding of HK-BCG on the intelectin-1-expressed RK-13 cells
RK-13 cells untransfected or transfected with human or mouse
intelectin-1 were cultured on 24-well plates with Eagle’s mini-
mum essential medium containing 5% fetal bovine serum. The
confluent cell monolayers were changed into 500 μL of fresh
medium and cultured for 2 days. The cells were incubated at
37◦C for 3 h with 500 μL of medium containing 50 μg of
FITC-BCG and washed four times with HBSC. After fixation
by 4% paraformaldehyde and staining with propidium iodide,
FITC-BCG captured on the cells was observed on a laser scan-
ning confocal microscope (Radiance 2100, Bio-Rad Labora-
tories, Inc., Hercules, CA). For flow cytometric analysis, the
FITC-BCG-bound cells were harvested from the unfixed cell
monolayers with HBSC by pipetting. The harvested cells were
washed twice by centrifugation and analyzed on a flow cytome-
ter (FACSCalibur, BD Biosciences, San Jose, CA).
BCG phagocytosis by mouse macrophages in the medium
containing mouse intelectin-1
Mouse alveolar macrophages were prepared from 8-week-old
C57BL/6 mice (Harlan Laboratory, Indianapolis, IN). The cells
(1 × 105 cells) in broncho-alveolar lavage were incubated
for 3 h in culture plates with RPMI1640 containing 5% fe-
tal bovine serum. After removing nonadherent cells, adherent
macrophages were cultured at 37◦C for 3 h with 500 μL of
medium containing 50 μg of HK-BCG, and then washed four
times with the medium. After fixation by 4% paraformaldehyde
and staining with propidium iodide, phagocytosed HK-BCG
was observed by a laser scanning confocal microscope (Ra-
diance 2100, Bio-Rad Laboratories, Inc., Hercules, CA). The
images were processed by Adobe Photoshop software.
Supplementary Data
Supplementary data for this article is available online at
http://glycob.oxfordjournals.org/.
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bovine serum albumin; EDTA, ethylenediamine tetra-
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piperazinyl]ethanesulfonic acid; HK-BCG, heat-killed BCG;
MALDI-TOF, matrix-assisted laser desorption/ionization time-
of-flight; MASPs, mannan binding lectin-associated serine pro-
teases; PI-PLC, phosphatidylinositol-specific phospholipase C;
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SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis; TBS, 20 mM Tris-buffered saline (pH 7.6).
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